Combretastatin A4 phosphate induces programmed cell death in vascular endothelial cells

Oncology Research

Volumn 19, Issue 7, 2011, Pages 303-309

  Ding, Xueqiang ^a   Zhang, Zhaoqiang ^a   Li, Su ^a   Wang, Anxun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Autophagy; Combretastatin A4 phosphate (CA4P); Programmed cell death

Indexed keywords

BIOLOGICAL MARKER; COMBRETASTATIN A4 PHOSPHATE; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA FRAGMENTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

EID: 80051876858     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504011X13079697132790     Document Type: Article

References (28)

1. Hayes, A. J.; Li, L. Y.; Lippman, M. E. Anti-vascular therapy: A new approach to cancer treatment. West. J. Med. 172:39-42; 2000.
2. Tozer, G. M.; Kanthou, C.; Baguley, B. C. Disrupting tu- mour blood vessels. Nat. Rev. Cancer 5:423-435; 2005.
3. Roodink, I.; Leenders, W. P. Targeted therapies of cancer: Angiogenesis inhibition seems not enough. Cancer Lett. 299:1-10; 2010.
4. Abdelrahim, M.; Konduri, S.; Basha, R.; Philip, P. A.; Baker, C. H. Angiogenesis: An update and potential drug approaches (review). Int. J. Oncol. 36:5-18; 2010.
5. Billard, C.; Menasria, F.; Quiney, C.; Faussat, A. M.; Finet, J. P.; Combes, S.; Kolb, J. P. 4-arylcoumarin anaother logues of combretastatins stimulate apoptosis of leukemic cells from chronic lymphocytic leukemia patients. Exp. Hematol. 36:1625-1633; 2008.
6. Gaya, A. M.; Rustin, G. J. Vascular disrupting agents: A new class of drug in cancer therapy. Clin. Oncol. (R Coll. Radiol.) 17:277-290; 2005.
7. Siemann, D. W.; Chaplin, D. J.; Walicke, P. A. A review and update of the current status of the vasculature-disatumor bling agent combretastatin-A4 phosphate (CA4P). Expert Opin. Investig. Drugs 18:189-197; 2009.
8. Vincent, L.; Kermani, P.; Young, L. M.; Cheng, J.; Zhang, F.; Shido, K.; Lam, G.; Bompais-Vincent, H.; Zhu, Z.; Hicklin, D. J.; Bohlen, P.; Chaplin, D. J.; May, C.; Rafii, S. Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling. J. Clin. Invest. 115:2992-3006; 2005.
9. Gridelli, C.; Rossi, A.; Maione, P.; Rossi, E.; Castaldo, V.; Sacco, P. C.; Colantuoni, G. Vascular disrupting agents: A novel mechanism of action in the battle against non-small cell lung cancer. Oncologist 14: 612-620; 2009.
10. Igney, F. H.; Krammer, P. H. Death and anti-death: Tuto mour resistance to apoptosis. Nat. Rev. Cancer 2:277-288; 2002.
11. Rizzo, M. T.; Leaver, H. A. Brain endothelial cell death: Modes, signaling pathways, and relevance to neural development, homeostasis, and Disease. Mol. Neurobiol. 42:52-63; 2010.
12. Nguyen, T. M.; Subramanian, I. V.; Kelekar, A.; Ramakrishnan, S. Kringle 5 of human plasminogen, an angiogenwe esis inhibitor, induces both autophagy and apoptotic death in endothelial cells. Blood 109:4793-4802; 2007.
13. Platini, F.; Perez-Tomas, R.; Ambrosio, S.; Tessitore, L. Understanding autophagy in cell death control. Curr. Pharm. Des. 16:101-113; 2010.
14. Vitale, I.; Antoccia, A.; Cenciarelli, C.; Crateri, P.; Meschini, S.; Arancia, G.; Pisano, C.; Tanzarella, C. Comapoptosis bretastatin CA-4 and combretastatin derivative induce mitotic catastrophe dependent on spindle checkpoint and caseffect pase-3 activation in non-small cell lung cancer cells. Apoptosis 12:155-166; 2007.
15. Fang, L.; He, Q.; Hu, Y.; Yang, B. MZ3 induces apoptosis in human leukemia cells. Cancer Chemother. Pharmacol. 59:397-405; 2007.
16. Medina, M. A.; Munoz-Chapuli, R.; Quesada, A. R. Chalangdong lenges of antiangiogenic cancer therapy: Trials and errors, and renewed hope. J. Cell. Mol. Med. 11:374-382; 2007.
17. Bohle, A. S.; Leuschner, I.; Kalthoff, H.; Henne-Bruns, D. Combretastatin A-4 prodrug: A potent inhibitor of malignant hemangioendothelioma cell proliferation. Int. J. Can1. cer 87:838-843; 2000.
18. Petit, I.; Karajannis, M. A.; Vincent, L.; Young, L.; Butler, J.; Hooper, A. T.; Shido, K.; Steller, H.; Chaplin, D. J.; Feldman, E.; Rafii, S. The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death. Blood 111:1951-1961; 2008.
19. Cooney, M. M.; Radivoyevitch, T.; Dowlati, A.; Overmoyer, B.; Levitan, N.; Robertson, K.; Levine, S. L.; DeCaro, K.; Buchter, C.; Taylor, A.; Stambler, B. S.; Remick, S. C. Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer. Clin. Cancer Res. 10:96-100; 2004.
20. Ahmed, B.; Van Eijk, L. I.; Bouma-Ter Steege, J. C.; Van BortezoDer Schaft, D. W.; Van Esch, A. M.; Joosten-Achjanie, S. R.; Lambin, P.; Landuyt, W.; Griffioen, A. W. Vascular targeting effect of combretastatin A-4 phosphate domi- nates the inherent angiogenesis inhibitory activity. Int. J. Cancer 105:20-25; 2003.
21. Hamze, A.; Giraud, A.; Messaoudi, S.; Provot, O.; Peyrat, J. F.; Bignon, J.; Liu, J. M.; Wdzieczak-Bakala, J.; Thoret, S.; Dubois, J.; Brion, J. D.; Alami, M. Synthesis, biological evaluation of 1,1-diarylethylenes as a novel class of autophagoantimitotic agents. ChemMedChem 4:1912-1924; 2009.
22. Baehrecke, E. H. Autophagy: Dual roles in life and death? Nat. Rev. Mol. Cell. Biol. 6:505-510; 2005.
23. Chintalapati, M.; Truax, R.; Stout, R.; Portier, R.; Losso, J. N. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate. J. Agric. Food Chem. 57:5201-5210; 2009.
24. Ramakrishnan, S.; Nguyen, T. M.; Subramanian, I. V.; Kelekar, A. Autophagy and angiogenesis inhibition. Autients tophagy 3:512-515; 2007.
25. Belloni, D.; Veschini, L.; Foglieni, C.; Dell'Antonio, G.; Caligaris-Cappio, F.; Ferrarini, M.; Ferrero, E. Bortezomib induces autophagic death in proliferating human en- dothelial cells. Exp. Cell Res. 316:1010-1018; 2010.
26. Yeung, S. C.; She, M.; Yang, H.; Pan, J.; Sun, L.; Chaplin, D. Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model. J. Clin. Endocrinol. Metab. 92:2902-2909; 2007.
27. Drake, K. R.; Kang, M.; Kenworthy, A. K. Nucleocycal toplasmic distribution and dynamics of the autophagoantimitotic some marker EGFP-LC3. PLoS One 5:e9806; 2010.
28. Kar, R.; Singha, P. K.; Venkatachalam, M. A.; Saikumar, P. A novel role for MAP1 LC3 in nonautophagic cyto23. plasmic vacuolation death of cancer cells. Oncogene 28: 2556-2568; 2009.